1-11 of 11
Authors: Mark Smithers
Journal Article
204. ALTERATIONS IN LOCAL OESOPHAGEAL MICROBIOTA AND OUTCOMES AFTER OESOPHAGECTOMY FOR OESOPHAGO-GASTRIC CANCER: A PILOT STUDY Free
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.006, https://doi.org/10.1093/dote/doae057.006
Published: 02 September 2024
Journal Article
378. GASTRIC FILLING IN NEOADJUVANT CHEMORADIOTHERAPY FOR OESOPHAGEAL CANCER Free
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.183, https://doi.org/10.1093/dote/doad052.183
Published: 30 August 2023
Journal Article
204. THE TUMOUR IMMUNE MICROENVIRONMENT IN OESOPHAGEAL ADENOCARCINOMA HAS PROGNOSTIC SIGNIFICANCE Free
Diseases of the Esophagus, Volume 35, Issue Supplement_2, September 2022, doac051.204, https://doi.org/10.1093/dote/doac051.204
Published: 24 September 2022
Journal Article
280. MULTI-OMIC FEATURES OF OESOPHAGEAL ADENOCARCINOMA PATIENTS PRE-TREATED WITH PREOPERATIVE NEOADJUVANT THERAPY Free
Diseases of the Esophagus, Volume 35, Issue Supplement_2, September 2022, doac051.280, https://doi.org/10.1093/dote/doac051.280
Published: 24 September 2022
Journal Article
406. COMPARISON OF OUTCOMES BETWEEN SALVAGE OESOPHAGECTOMY AFTER DEFINITIVE CHEMORADIOTHERAPY WITH PLANNED OESOPHAGECTOMY AFTER NEOADJUVANT CHEMORADIOTHERAPY Free
Diseases of the Esophagus, Volume 35, Issue Supplement_2, September 2022, doac051.406, https://doi.org/10.1093/dote/doac051.406
Published: 24 September 2022
Journal Article
320. EFFICACY OF LAPAROSCOPIC FUNDOPLICATION IN PATIENTS WITH CHRONIC COUGH AND GASTRO-OESOPHAGEAL REFLUX Free
Diseases of the Esophagus, Volume 35, Issue Supplement_2, September 2022, doac051.320, https://doi.org/10.1093/dote/doac051.320
Published: 24 September 2022
Journal Article
Identifying a core symptom set triggering radiological and endoscopic investigations for suspected recurrent esophago-gastric cancer: a modified Delphi consensus process Open Access
Diseases of the Esophagus, Volume 36, Issue 1, January 2023, doac038, https://doi.org/10.1093/dote/doac038
Published: 21 July 2022
Journal Article
FA03.05: NEOADJUVANT CHEMOTHERAPY OR CHEMORADIOTHERAPY FOR ADENOCARCINOMA OF THE ESOPHAGUS Get access
Diseases of the Esophagus, Volume 31, Issue Supplement_1, September 2018, Page 7, https://doi.org/10.1093/dote/doy089.FA03.05
Published: 14 September 2018
Journal Article
RA10.05: CHEMORADIOTHERAPY IMPROVES LOCO-REGIONAL CONTROL AND DISEASE-FREE SURVIVAL OVER CHEMOTHERAPY IN OESOPHAGEAL ADENOCARCINOMA WITH SIGNET RING MORPHOLOGY Get access
Diseases of the Esophagus, Volume 31, Issue Supplement_1, September 2018, Page 43, https://doi.org/10.1093/dote/doy089.RA10.05
Published: 14 September 2018
Journal Article
PS02.207: NEUTROPHIL-LYMPHOCYTE RATIO HOLDS NO PROGNOSTIC VALUE FOR OESOPHAGEAL AND JUNCTIONAL ADENOCARCINOMA IN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY Get access
Diseases of the Esophagus, Volume 31, Issue Supplement_1, September 2018, Page 181, https://doi.org/10.1093/dote/doy089.PS02.207
Published: 14 September 2018
Journal Article
PS01.176: OPEN VERSUS HYBRID VERSUS MINIMALLY INVASIVE ESOPHAGECTOMY FOR PATIENTS WITH ESOPHAGEAL CANCER: A PROPENSITY SCORE MATCHED ANALYSIS Get access
Diseases of the Esophagus, Volume 31, Issue Supplement_1, September 2018, Pages 99–100, https://doi.org/10.1093/dote/doy089.PS01.176
Published: 14 September 2018
